Here's Why You Should Add HealthEquity Stock to Your Portfolio Now

HealthEquity (HQY) is experiencing growth driven by its Health Savings Account (HSA) offerings, with HSAs increasing 14% year-over-year to 9.9 million and total HSA assets rising 27% to $32.1 billion as of January 31, 2025; Q4 fiscal 2025 revenues increased 19% to $311.8 million. The company projects fiscal 2026 revenues between $1.28 billion and $1.305 billion and EPS between $3.57 and $3.74, however, a significant data breach impacting approximately 4.3 million individuals underscores cybersecurity risks and has led to a negative estimate revision trend for fiscal 2026.

Analysis

HealthEquity (HQY) is demonstrating robust growth, evidenced by a 14% year-over-year increase in Health Savings Accounts (HSAs) to 9.9 million and a 27% rise in total HSA assets to $32.1 billion as of January 31, 2025. This momentum contributed to a strong fourth-quarter fiscal 2025, where revenues rose 19% year-over-year to $311.8 million and the bottom line improved 9.5%. Year-to-date, HQY's shares have appreciated 5.8%, outperforming its industry's 4.8% decline and the S&P 500's 0.2% increase. The company projects continued expansion, with fiscal 2026 revenue guidance between $1.28 billion and $1.305 billion and earnings per share (EPS) between $3.57 and $3.74, supported by an earnings surprise history averaging 12.78% in three of the last four quarters. However, these positive fundamentals are significantly counterbalanced by a major data security incident; a data breach occurring on March 9, 2024, and discovered on June 26, 2024, impacted approximately 4.3 million individuals, posing substantial operational, reputational, and potential legal and financial risks. This concern is reflected in a negative estimate revision trend for fiscal 2026, where the Zacks Consensus Estimate for EPS has declined by 3 cents to $3.60 over the past 60 days, despite the stock holding a Zacks Rank #2 (Buy).

Key Decisions for Investors

• Investors should carefully weigh HealthEquity's strong HSA-driven growth, positive financial performance, and market outperformance against the significant operational and reputational risks stemming from the recent major data breach.
• It is crucial to closely monitor further disclosures regarding the data breach's impact, including potential regulatory fines, legal expenses, customer attrition, and the effectiveness of remediation measures, as these will directly affect future profitability and shareholder value.
• Consider the recent downward revisions in fiscal 2026 EPS estimates as a potential leading indicator of challenges ahead, and assess whether the current valuation adequately reflects the heightened risk profile associated with the cybersecurity incident, even with its current 'Buy' rating.